Tariffs and material cost pressures remain the twin anchors on supply chain angst. While these challenges are familiar, they’re now joined by growing worry over environmental regulation and labor constraints—signs that companies are not just dealing with short-term issues, but longer-term stress.
The policy backdrop intensified in Q3. In August, President Trump added a 25% penal tariff on Indian goods—on top of existing reciprocal duties—raising the total tariff on many imports from India to 50%. Then in late September, the administration announced a 100% tariff on imported branded and patented pharmaceuticals, effective October 1. While generics are excluded and companies building U.S. plants may qualify for exemptions, implementation has already been partially paused to allow for negotiation. The back-and-forth underscores how unpredictable tariff policy has become, keeping leaders on edge throughout 2025.
Against this backdrop, executives are weighing what a Supreme Court ruling on tariffs could mean. In our poll, 68% say removing tariffs would benefit their supply chains—citing stronger sales, fewer constant adjustments, greater planning stability, and reduced administrative burden. Just 15% expect a negative impact, pointing to wasted diversification efforts and added complexity from unwinding changes.